Filter News
Area of Research
- Advanced Manufacturing (3)
- Biology and Environment (27)
- Clean Energy (61)
- Computational Engineering (1)
- Computer Science (3)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (18)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (16)
- Materials (67)
- Materials Characterization (1)
- Materials for Computing (8)
- Materials Under Extremes (1)
- National Security (23)
- Neutron Science (23)
- Nuclear Science and Technology (11)
- Quantum information Science (1)
- Supercomputing (39)
News Type
News Topics
- (-) Artificial Intelligence (39)
- (-) Biomedical (28)
- (-) Clean Water (9)
- (-) Composites (14)
- (-) Cybersecurity (23)
- (-) Energy Storage (57)
- (-) Frontier (18)
- (-) Hydropower (2)
- (-) Isotopes (30)
- (-) Materials Science (64)
- (-) Nuclear Energy (42)
- 3-D Printing/Advanced Manufacturing (58)
- Advanced Reactors (12)
- Big Data (14)
- Bioenergy (40)
- Biology (44)
- Biotechnology (12)
- Buildings (25)
- Chemical Sciences (41)
- Climate Change (37)
- Computer Science (73)
- Coronavirus (23)
- Critical Materials (13)
- Decarbonization (36)
- Education (3)
- Element Discovery (1)
- Environment (73)
- Exascale Computing (13)
- Fossil Energy (1)
- Fusion (23)
- Grid (22)
- High-Performance Computing (39)
- ITER (3)
- Machine Learning (19)
- Materials (66)
- Mathematics (4)
- Mercury (6)
- Microelectronics (1)
- Microscopy (25)
- Molten Salt (3)
- Nanotechnology (32)
- National Security (34)
- Net Zero (5)
- Neutron Science (59)
- Partnerships (30)
- Physics (40)
- Polymers (17)
- Quantum Computing (11)
- Quantum Science (29)
- Renewable Energy (1)
- Security (17)
- Simulation (13)
- Space Exploration (3)
- Statistics (1)
- Summit (23)
- Sustainable Energy (44)
- Transformational Challenge Reactor (4)
- Transportation (37)
Media Contacts
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
Ask Tyler Gerczak to find a negative in working at the Department of Energy’s Oak Ridge National Laboratory, and his only complaint is the summer weather. It is not as forgiving as the summers in Pulaski, Wisconsin, his hometown.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
A team led by scientists at the Department of Energy’s Oak Ridge National Laboratory explored how atomically thin two-dimensional (2D) crystals can grow over 3D objects and how the curvature of those objects can stretch and strain the
OAK RIDGE, Tenn., May 7, 2019—The U.S. Department of Energy today announced a contract with Cray Inc. to build the Frontier supercomputer at Oak Ridge National Laboratory, which is anticipated to debut in 2021 as the world’s most powerful computer with a performance of greater than 1.5 exaflops.
OAK RIDGE, Tenn., May 7, 2019—Energy Secretary Rick Perry, Congressman Chuck Fleischmann and lab officials today broke ground on a multipurpose research facility that will provide state-of-the-art laboratory space
Kevin Field at the Department of Energy’s Oak Ridge National Laboratory synthesizes and scrutinizes materials for nuclear power systems that must perform safely and efficiently over decades of irradiation.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.